{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:44:53Z","timestamp":1785343493398,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T00:00:00Z","timestamp":1554422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471173"],"award-info":[{"award-number":["81471173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571109"],"award-info":[{"award-number":["81571109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"crossref","award":["16411970200"],"award-info":[{"award-number":["16411970200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["16JC1400500"],"award-info":[{"award-number":["16JC1400500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2017YFC0111902"],"award-info":[{"award-number":["2017YFC0111902"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12974-019-1460-1","type":"journal-article","created":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T07:03:29Z","timestamp":1554447809000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Highly glycosylated CD147 promotes hemorrhagic transformation after rt-PA treatment in diabetes: a novel therapeutic target?"],"prefix":"10.1186","volume":"16","author":[{"given":"Yanan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6449-8106","authenticated-orcid":false,"given":"Mei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,5]]},"reference":[{"key":"1460_CR1","doi-asserted-by":"publisher","unstructured":"Wan E, Fung C, Yu E, Chin WY, Fong D, Chan A, et al. Effect of multifactorial treatment targets and relative importance of hemoglobin A1c, blood pressure, and low-density lipoprotein-cholesterol on cardiovascular diseases in Chinese primary care patients with type 2 diabetes mellitus: a population-based retrospective cohort study. J Am Heart Assoc. 2017;6. \n                    https:\/\/doi.org\/10.1161\/JAHA.117.006400\n                    \n                  . PMID: 28862945","DOI":"10.1161\/JAHA.117.006400"},{"key":"1460_CR2","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"WN Kernan","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014;45:2160\u2013236.","journal-title":"Stroke"},{"key":"1460_CR3","doi-asserted-by":"publisher","unstructured":"Wang Z, Li J, Wang C, Yao X, Zhao X, Wang Y, et al. Gender differences in 1-year clinical characteristics and outcomes after stroke: results from the China National Stroke Registry. PLoS One. 2013;8. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0056459\n                    \n                  . PMID: 23418571.","DOI":"10.1371\/journal.pone.0056459"},{"key":"1460_CR4","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1016\/S0140-6736(12)60768-5","volume":"379","author":"P Sandercock","year":"2012","unstructured":"Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012;379:2352\u201363.","journal-title":"Lancet"},{"issue":"1","key":"1460_CR5","first-page":"1","volume":"26","author":"CY Hsieh","year":"2017","unstructured":"Hsieh CY. Intravenous alteplase for acute ischemic stroke in Taiwan: can we expand the National Health Insurance\u2019s reimbursement criteria? Acta Neurol Taiwanica. 2017;26(1):1\u20132.","journal-title":"Acta Neurol Taiwanica"},{"key":"1460_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0140-6736(04)15692-4","volume":"363","author":"W Hacke","year":"2004","unstructured":"Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768\u201374.","journal-title":"Lancet"},{"key":"1460_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5551\/jat.RV16006","volume":"24","author":"M Kanazawa","year":"2017","unstructured":"Kanazawa M, Takahashi T, Nishizawa M, Shimohata T. Therapeutic strategies to attenuate hemorrhagic transformation after tissue plasminogen activator treatment for acute ischemic stroke. J Atheroscler Thromb. 2017;24:240\u201353.","journal-title":"J Atheroscler Thromb"},{"key":"1460_CR8","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1503\/cmaj.1041561","volume":"172","author":"MD Hill","year":"2005","unstructured":"Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ. 2005;172:1307\u201312.","journal-title":"CMAJ"},{"key":"1460_CR9","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1212\/WNL.57.9.1603","volume":"57","author":"CS Kase","year":"2001","unstructured":"Kase CS, Furlan AJ, Wechsler LR, Higashida RT, Rowley HA, Hart RG, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology. 2001;57:1603\u201310.","journal-title":"Neurology"},{"key":"1460_CR10","doi-asserted-by":"crossref","unstructured":"Jaillard A, Cornu C, Durieux A, Moulin T, Boutitie F, Lees KR, et al. Hemorrhagic transformation in acute ischemic stroke: the MAST-E study. MAST-E Group. Stroke 1999;30:1326\u20131332.","DOI":"10.1161\/01.STR.30.7.1326"},{"key":"1460_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/01.STR.30.1.34","volume":"30","author":"AM Demchuk","year":"1999","unstructured":"Demchuk AM, Morgenstern LB, Krieger DW, Linda CT, Hu W, Wein TH, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999;30:34\u20139.","journal-title":"Stroke"},{"key":"1460_CR12","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1038\/jcbfm.2010.120","volume":"30","author":"MM Elgebaly","year":"2010","unstructured":"Elgebaly MM, Prakash R, Li W, Ogbi S, Johnson MH, Mezzetti EM, et al. Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling. J Cereb Blood Flow Metab. 2010;30:1928\u201338.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1460_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/STROKEAHA.107.500868","volume":"39","author":"A Rosell","year":"2008","unstructured":"Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo EH, Montaner J. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke. 2008;39:1121\u20136.","journal-title":"Stroke"},{"key":"1460_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/glia.20169","volume":"50","author":"LA Cunningham","year":"2005","unstructured":"Cunningham LA, Wetzel M, Rosenberg GA. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia. 2005;50:329\u201339.","journal-title":"Glia"},{"key":"1460_CR15","doi-asserted-by":"publisher","first-page":"H806","DOI":"10.1152\/ajpheart.00720.2012","volume":"304","author":"AI Kelly-Cobbs","year":"2013","unstructured":"Kelly-Cobbs AI, Prakash R, Li W, Pillai B, Hafez S, Coucha M, et al. Targets of vascular protection in acute ischemic stroke differ in type 2 diabetes. Am J Physiol Heart Circ Physiol. 2013;304:H806\u201315.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1460_CR16","first-page":"434","volume":"55","author":"C Biswas","year":"1995","unstructured":"Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, et al. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995;55:434\u20139.","journal-title":"Cancer Res"},{"key":"1460_CR17","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.3390\/ijms15046356","volume":"15","author":"Y Bai","year":"2014","unstructured":"Bai Y, Huang W, Ma LT, Jiang JL, Chen ZN. Importance of N-glycosylation on CD147 for its biological functions. Int J Mol Sci. 2014;15:6356\u201377.","journal-title":"Int J Mol Sci"},{"key":"1460_CR18","doi-asserted-by":"publisher","first-page":"C1212","DOI":"10.1152\/ajpcell.00228.2010","volume":"299","author":"W Bao","year":"2010","unstructured":"Bao W, Min D, Twigg SM, Shackel NA, Warner FJ, Yue DK, et al. Monocyte CD147 is induced by advanced glycation end products and high glucose concentration: possible role in diabetic complications. Am J Physiol Cell Physiol. 2010;299:C1212\u20139.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1460_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1161\/STROKEAHA.111.635250","volume":"43","author":"X Fan","year":"2012","unstructured":"Fan X, Qiu J, Yu Z, Dai H, Singhal AB, Lo EH, et al. A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes. Stroke. 2012;43:567\u201370.","journal-title":"Stroke"},{"key":"1460_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12035-014-9002-4","volume":"53","author":"M Cui","year":"2016","unstructured":"Cui M, Ding H, Chen F, Zhao Y, Yang Q, Dong Q. Mdivi-1 protects against ischemic brain injury via elevating extracellular adenosine in a cAMP\/CREB-CD39-dependent manner. Mol Neurobiol. 2016;53:240\u201353.","journal-title":"Mol Neurobiol"},{"key":"1460_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-016-0661-0","volume":"13","author":"F Chen","year":"2016","unstructured":"Chen F, Wang W, Ding H, Yang Q, Dong Q, Cui M. The glucagon-like peptide-1 receptor agonist exendin-4 ameliorates warfarin-associated hemorrhagic transformation after cerebral ischemia. J Neuroinflammation. 2016;13:204.","journal-title":"J Neuroinflammation"},{"key":"1460_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/cns.12266","volume":"20","author":"YX Zhao","year":"2014","unstructured":"Zhao YX, Cui M, Chen SF, Dong Q, Liu XY. Amelioration of ischemic mitochondrial injury and Bax-dependent outer membrane permeabilization by Mdivi-1. CNS Neurosci Ther. 2014;20:528\u201338.","journal-title":"CNS Neurosci Ther"},{"key":"1460_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1161\/01.STR.24.1.117","volume":"24","author":"TN Lin","year":"1993","unstructured":"Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993;24:117\u201321.","journal-title":"Stroke"},{"key":"1460_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.23762","volume":"73","author":"L Wang","year":"2013","unstructured":"Wang L, Fan W, Cai P, Fan M, Zhu X, Dai Y, et al. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice. Ann Neurol. 2013;73:189\u201398.","journal-title":"Ann Neurol"},{"key":"1460_CR25","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1471-4159.2006.03793.x","volume":"97","author":"AR Calabria","year":"2006","unstructured":"Calabria AR, Weidenfeller C, Jones AR, de Vries HE, Shusta EV. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J Neurochem. 2006;97:922\u201333.","journal-title":"J Neurochem"},{"key":"1460_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1042\/BJ20120343","volume":"449","author":"W Huang","year":"2013","unstructured":"Huang W, Luo WJ, Zhu P, Tang J, Yu XL, Cui HY, et al. Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation. Biochem J. 2013;449:437\u201348.","journal-title":"Biochem J"},{"key":"1460_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2016.02.020","volume":"91","author":"W Zhang","year":"2016","unstructured":"Zhang W, Zhang H, Mu H, Zhu W, Jiang X, Hu X, et al. Omega-3 polyunsaturated fatty acids mitigate blood-brain barrier disruption after hypoxic-ischemic brain injury. Neurobiol Dis. 2016;91:37\u201346.","journal-title":"Neurobiol Dis"},{"key":"1460_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.expneurol.2006.01.032","volume":"200","author":"MA Kelly","year":"2006","unstructured":"Kelly MA, Shuaib A, Todd KG. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp Neurol. 2006;200:38\u201349.","journal-title":"Exp Neurol"},{"key":"1460_CR29","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/ejn.12552","volume":"39","author":"K Rakkar","year":"2014","unstructured":"Rakkar K, Srivastava K, Bayraktutan U. Attenuation of urokinase activity during experimental ischaemia protects the cerebral barrier from damage through regulation of matrix metalloproteinase-2 and NAD(P) H oxidase. Eur J Neurosci. 2014;39:2119\u201328.","journal-title":"Eur J Neurosci"},{"key":"1460_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.nbd.2010.03.008","volume":"38","author":"R Jin","year":"2010","unstructured":"Jin R, Yang G, Li G. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis. 2010;38:376\u201385.","journal-title":"Neurobiol Dis"},{"key":"1460_CR31","doi-asserted-by":"publisher","first-page":"11112","DOI":"10.1074\/jbc.M312947200","volume":"279","author":"W Tang","year":"2004","unstructured":"Tang W, Hemler ME. Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147\/EMMPRIN cell surface clustering. J Biol Chem. 2004;279:11112\u20138.","journal-title":"J Biol Chem"},{"key":"1460_CR32","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/ijc.24531","volume":"125","author":"ZM Du","year":"2009","unstructured":"Du ZM, Hu CF, Shao Q, Huang MY, Kou CW, Zhu XF, et al. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int J Cancer. 2009;125:1832\u201341.","journal-title":"Int J Cancer"},{"key":"1460_CR33","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1091\/mbc.e04-05-0402","volume":"15","author":"W Tang","year":"2004","unstructured":"Tang W, Chang SB, Hemler ME. Links between CD147 function, glycosylation, and caveolin-1. Mol Biol Cell. 2004;15:4043\u201350.","journal-title":"Mol Biol Cell"},{"key":"1460_CR34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/STR.0000000000000086","volume":"47","author":"BM Demaerschalk","year":"2016","unstructured":"Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2016;47:581\u2013641.","journal-title":"Stroke"},{"key":"1460_CR35","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.matbio.2015.01.018","volume":"44-46","author":"DK Kaushik","year":"2015","unstructured":"Kaushik DK, Hahn JN, Yong VW. EMMPRIN, an upstream regulator of MMPs, in CNS biology. Matrix Biol. 2015;44-46:138\u201346.","journal-title":"Matrix Biol"},{"key":"1460_CR36","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.2337\/diabetes.51.10.3063","volume":"51","author":"V Portik-Dobos","year":"2002","unstructured":"Portik-Dobos V, Anstadt MP, Hutchinson J, Bannan M, Ergul A. Evidence for a matrix metalloproteinase induction\/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes. 2002;51:3063\u20138.","journal-title":"Diabetes"},{"key":"1460_CR37","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/aos.13284","volume":"95","author":"EA Abu","year":"2017","unstructured":"Abu EA, Ahmad A, Alam K, Siddiquei MM, Mohammad G, Hertogh G, et al. Extracellular matrix metalloproteinase inducer (EMMPRIN) is a potential biomarker of angiogenesis in proliferative diabetic retinopathy. Acta Ophthalmol. 2017;95:697\u2013704.","journal-title":"Acta Ophthalmol"},{"issue":"Suppl 1","key":"1460_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000074791","volume":"17","author":"J Castillo","year":"2004","unstructured":"Castillo J, Rodriguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis. 2004;17(Suppl 1):7\u201318.","journal-title":"Cerebrovasc Dis"},{"key":"1460_CR39","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jocn.2010.01.005","volume":"17","author":"J Kurzepa","year":"2010","unstructured":"Kurzepa J, Bielewicz J, Grabarska A, Stelmasiak Z, Stryjecka-Zimmer M, Bartosik-Psujek H. Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke. J Clin Neurosci. 2010;17:997\u20139.","journal-title":"J Clin Neurosci"},{"key":"1460_CR40","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.bcp.2013.04.006","volume":"85","author":"H Yamada","year":"2013","unstructured":"Yamada H, Yoneda M, Inaguma S, Watanabe D, Banno S, Yoshikawa K, et al. Infliximab counteracts tumor necrosis factor-alpha-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium. Biochem Pharmacol. 2013;85:1770\u201382.","journal-title":"Biochem Pharmacol"},{"key":"1460_CR41","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.biocel.2006.03.019","volume":"38","author":"L Jia","year":"2006","unstructured":"Jia L, Wang S, Zhou H, Cao J, Hu Y, Zhang J. Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines. Int J Biochem Cell Biol. 2006;38:1584\u201393.","journal-title":"Int J Biochem Cell Biol"},{"key":"1460_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00395-015-0476-7","volume":"110","author":"E Robinson","year":"2015","unstructured":"Robinson E, Cassidy RS, Tate M, Zhao Y, Lockhart S, Calderwood D, et al. Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix. Basic Res Cardiol. 2015;110:20.","journal-title":"Basic Res Cardiol"},{"key":"1460_CR43","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2337\/dc16-1957","volume":"40","author":"MI Maiorino","year":"2017","unstructured":"Maiorino MI, Chiodini P, Bellastella G, Capuano A, Esposito K, Giugliano D. Insulin and glucagon-like peptide 1 receptor agonist combination therapy in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2017;40:614\u201324.","journal-title":"Diabetes Care"},{"key":"1460_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1161\/STROKEAHA.112.663476","volume":"44","author":"X Fan","year":"2013","unstructured":"Fan X, Ning M, Lo EH, Wang X. Early insulin glycemic control combined with tPA thrombolysis reduces acute brain tissue damages in a focal embolic stroke model of diabetic rats. Stroke. 2013;44:255\u20139.","journal-title":"Stroke"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-019-1460-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-019-1460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T23:07:50Z","timestamp":1585955270000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-019-1460-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,5]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1186\/s12974-019-1460-1","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,5]]},"assertion":[{"value":"25 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out following the Guide for the National Science Council of the People\u2019s Republic of China.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"72"}}